On the solution conformation and dynamics of the HIV-1 viral infectivity factor
about
HIV Genome-Wide Protein Associations: a Review of 30 Years of ResearchMultiple APOBEC3 restriction factors for HIV-1 and one Vif to rule them allCharacterization of the interaction of full-length HIV-1 Vif protein with its key regulator CBFβ and CRL5 E3 ubiquitin ligase componentsStructural analysis of viral infectivity factor of HIV type 1 and its interaction with A3G, EloC and EloBPartial cooperative unfolding in proteins as observed by hydrogen exchange mass spectrometry.Integrating mass spectrometry of intact protein complexes into structural proteomicsCharacterization of RNA binding and chaperoning activities of HIV-1 Vif protein. Importance of the C-terminal unstructured tail.Structural insights for HIV-1 therapeutic strategies targeting Vif.Codon pairs of the HIV-1 vif gene correlate with CD4+ T cell countThe activity spectrum of Vif from multiple HIV-1 subtypes against APOBEC3G, APOBEC3F, and APOBEC3HEpitope-distal effects accompany the binding of two distinct antibodies to hepatitis B virus capsids.Membrane phospholipid bilayer as a determinant of monoacylglycerol lipase kinetic profile and conformational repertoire.Inhibition of CD73 AMP hydrolysis by a therapeutic antibody with a dual, non-competitive mechanism of action.Active-site inhibitors modulate the dynamic properties of human monoacylglycerol lipase: a hydrogen exchange mass spectrometry studyThe assembly of Vif ubiquitin E3 ligase for APOBEC3 degradation.Proteomics in the investigation of HIV-1 interactions with host proteins.CBFβ stabilizes HIV Vif to counteract APOBEC3 at the expense of RUNX1 target gene expression.
P2860
Q26746070-7170ED99-8FF4-4ECA-B3F2-7F6BFFD5651EQ26823568-760339A1-569B-4F65-A833-78B9C1130A03Q28482052-60AE2AE9-0638-4498-AC45-E22189FA9263Q28540150-7AACA123-7708-4D72-B0DD-447494A8E282Q30009855-0B649133-64A9-4F6C-BC0B-B40EDA505532Q30417001-3BB4CAA3-5227-4D17-B5F2-DF6D6A7B60B2Q34266485-CB549A93-B984-4432-8D00-5D65C6B80D4BQ34433647-4B852735-4922-4139-B2B2-AE3A1FEBC025Q34665129-C36813C8-FD7F-4720-AFD8-85A3C3518BC0Q35666084-992DDC1D-DF6B-4A72-90C6-B8C9BBCE0A4AQ36856227-1F9499BF-EE19-46ED-801A-C1AC9922E44AQ36949890-718682E0-1362-4FFE-BA74-C87AE0E51E0BQ37287000-F956DDB7-6F73-4CDD-9DEC-B8DD59605655Q37374110-99885FA4-55BA-4CF5-81E0-ACBA63C98D14Q38269459-3119D5FF-9CD9-4F4B-9D9A-71CFB922D8D9Q38293944-2DBDE8AF-3BA3-4E97-8076-9D033CB1C607Q43239447-6F9C215B-65F7-42EA-A51B-1D585BAA8854
P2860
On the solution conformation and dynamics of the HIV-1 viral infectivity factor
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
On the solution conformation and dynamics of the HIV-1 viral infectivity factor
@ast
On the solution conformation and dynamics of the HIV-1 viral infectivity factor
@en
type
label
On the solution conformation and dynamics of the HIV-1 viral infectivity factor
@ast
On the solution conformation and dynamics of the HIV-1 viral infectivity factor
@en
prefLabel
On the solution conformation and dynamics of the HIV-1 viral infectivity factor
@ast
On the solution conformation and dynamics of the HIV-1 viral infectivity factor
@en
P2093
P2860
P1476
On the solution conformation and dynamics of the HIV-1 viral infectivity factor
@en
P2093
Lori A Emert-Sedlak
Marek Kloczewiak
Purushottam S Narute
Sean R Marcsisin
Thomas E Smithgall
P2860
P304
P356
10.1016/J.JMB.2011.04.053
P407
P577
2011-07-01T00:00:00Z